Medtronic PLC
(LTS:0Y6X)
$
81.63
1.13 (1.41%)
Market Cap: 104.56 Bil
Enterprise Value: 125.12 Bil
PE Ratio: 25.24
PB Ratio: 2.18
GF Score: 78/100 Medtronic PLC at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 15, 2022 / 01:10PM GMT
Release Date Price:
$91.5
(+1.45%)
Travis Lee Steed
BofA Securities, Research Division - MD
(technical difficulty)
Robert J. W. ten Hoedt
Medtronic plc - Executive VP and President, Europe, Middle East, Africa Region & Asia Pacific
That is the de novo patients plus the deferred patients should all be treated then we're going to get this increase in productivity. That happened in Spain and Italy, but it didn't in France, in the U.K. and in Germany. So these big markets, they have massive staffing issues. And so we see production coming back to pre-COVID levels, but we -- they cannot handle to deferred patients wave that's coming at them. APAC has not seen any of the issues with staffing. So we are basically just back at the levels that we were before COVID.
Questions & Answers
Travis Lee Steed;
BofA Securities, Research Division - MD
In terms of procedural volumes, we're pretty much back at kind of pre-COVID levels, normalized volumes and that's the plan from here. Maybe as staffing eases, we could see some recovery.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot